Viral Haemorrhagic Fevers

exp date isn't null, but text field is

Ebola and Marburg

ICD11 CODE: A99

Ebola and Marburg are severe zoonotic multisystem febrile diseases caused by RNA viruses. They are notifiable diseases.

Cause

  • Ebola and Marburg viruses. Transmission to humans happens through contact with meat or body fluids of an infected animal. The disease can then be transmitted from human to human through body fluids (including semen for months after recovery) and it is highly contagious.

Risk factors

  • Communities around game parks
  • Communities in endemic area
  • Cultural practices like burial rituals
  • Poor infection control policies
  • History of exposure to infected people in the last 2 to 21 days i.e sexual partner, breastfeeding mothers
  • Recent contact with infected animals e.g monkeys, bats, infected game meat

Clinical features

  • Early signs (non specific): sudden fever, weakness, headache, muscle pains, loss of appetite, conjunctivitis
  • Late signs:
    • Diarrhoea (watery or bloody), vomiting
    • Mucosal and gastrointestinal bleeding: chest pain, respiratory distress, circulatory shock
    • CNS dysfunction, confusion, seizures
    • Miscarriage in pregnancy
    • Elevated AST and ALT, kidney injury, electrolyte abnormalities

Note: Haemorrhage is seen in less than a third of Ebola patients

Differential diagnosis

  • Malaria, rickettsiosis, meningitis
  • Shigellosis, typhoid
  • Anthrax, sepsis, viral hepatitis, dengue, leptospirosis

Investigations

  • Send blood sample to a referral laboratory for specific testing (taking off blood samples from patients suspected of viral hemorrhagic fever should be done by a trained healthcare worker in appropriate PPE.

  • Notify district surveillance focal person

Management

Treatment LOC
  • Refer all patients to regional referral hospital for management in an appropriate setting
  • Notify the district health team
RR

 

Safety of health workers: maximum level of infection control procedures

Health workers should maintain a high level of suspicion for Ebola virus disease. While standard precautions should be followed for all patients at all times, implementation of transmission-based precautions for cases suspected or confirmed to have Ebola or Marburg virus diseases is essential. This includes: screening for rapid identification and isolation of cases.

Hand hygiene according to the WHO 5 moments safe injection practices use of personal protective equipment (e.g. eye protection, mask (medical or respirator), gloves, gown or coverall, head covering, apron and gum (rubber) boots.

Handling and disposing of all waste related to the care of an Ebola patients as infectious

Safe handling and disinfection of linens (or disposal if not possible) and thorough cleaning and disinfection of the environment and medical equipment.

Disinfectants (e.g. chlorine mixture of 0.5% for surfaces) used must be prepared and used ensuring adequate concentration and contact time on surfaces.

Handling of the deceased is particularly high risk and should be kept to a minimum. Strict adherence to IPC measures including hand hygiene, use of personal protective equipment (e.g. eye protection, mask (medical or respirator), gloves, gown or coverall, head covering, apron and gum (rubber) boots is required.

Patient care

  • Refer to the MoH recent guidelines for management of viral hemorrhagic fevers
  • Optimised supportive treatment of signs and symptoms
  • Replace and monitor fluids and electrolytes for patients with diarrhoea or vomiting

Triage and contact tracing

  • Triage patient (those who had contact with a patient or not)
  • Contact identification, contact listing and contact follow up

Dead Body handling

  • Avoid washing or touching the dead
  • There should be no gathering at funerals
  • The dead should be buried promptly by a designated burial team

Prevention

  • Health education of the population (e.g. avoid eating wild animals)
  • Effective outbreak communication and having haemorrhagic viral fever protocols in place
  • Appropriate safety gear for patients/health workers in suspect cases
  • Modification of burial practices
  • Use of condoms

Yellow Fever

An acute viral haemorrhagic fever transmitted through the bite of infected female Aedes aegypti mosquito. Incubation period is 3 to 6 days. It is a notifiable disease.

Cause

  • Yellow fever RNA virus

Risk factors

  • Residents in endemic area
  • Hunters and settlers around game parks

Clinical Features

First stage:

  • Fever, chills, headache, backache, muscle pain, prostration, nausea, vomiting, fatigue. Usually resolves within 3-4 days.

Second stage:

  • About 15% of cases enter into a second or toxic stage after 1-2 day of remission: high fever, prostration, signs and symptoms of hepatic failure, renal failure and bleeding (jaundice, nose bleeding, gingival bleeding, vomiting blood, blood in stool)
  • About half of these patients die within 7-10 days

Differential diagnosis

  • Hepatitis E, liver failure
  • Malaria, Ebola

Investigations

  • PCR in early phases
  • ELISA in the late stage

Management

Treatment LOC
  • Refer all cases to regional referral hospital
  • Notify the district health team
  • There is no specific antiviral drug treatment
  • Supportive treatment is recommended:
    • Rehydration
    • Management of liver and kidney failure
    • Antipyretics for fever
    • Blood transfusion
  • Treat associated bacterial infections with antibiotics 
RR

Note: Individuals who have recovered from a yellow fever infection develop life-long immunity 

Prevention

  • Vaccination (see Immunizations)
  • Elimination of mosquito breeding sites
  • Epidemic preparedness i.e prompt detection and treatment